Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice (Q50759965)

18 March 2018

title

Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice (English)

1 reference

18 March 2018

main subject

Astragalus membranaceus

1 reference

Zhi-Gang Yang

1

1 reference

18 March 2018

Hong-Xiang Sun

series ordinal

2

1 reference

18 March 2018

Wei-Huan Fang

series ordinal

3

1 reference

18 March 2018

language of work or name

English

0 references

publication date

1 October 2005

1 reference

18 March 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

18 March 2018

volume

23

1 reference

18 March 2018

issue

44

1 reference

18 March 2018

page(s)

5196-5203

1 reference

18 March 2018

Recent developments in adjuvants for vaccines against infectious diseases

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Adjuvants designed for veterinary and human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Adjuvants--a classification and review of their modes of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

The effect of various adjuvants on the humoral immune response of sheep and cattle to soluble and membrane midgut antigens of Boophilus microplus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

The immunomodulatory effect of saikosaponin derivatives and the root extract ofBupleurum kaoi in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Adjuvant effect of ginseng extracts on the immune responses to immunisation against Staphylococcus aureus in dairy cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Induction of CD8 cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Isomerization and formulation stability of the vaccine adjuvant QS-21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

QS-21 structure/function studies: effect of acylation on adjuvant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Protective effects of Astragalus saponin I on early stage of diabetic nephropathy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Cycloartane saponins from Astragalus peregrinus as modulators of lymphocyte proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Cycloartane triterpene glycosides from astragalus trigonus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Immunostimulatory effects of cycloartane-type triterpene glycosides from astragalus species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

A review of the pharmacology and toxicology ofAstragalus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Haemolytic time course differences between steroid and triterpenoid saponins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Immunological-adjuvant saponins from the roots of Panax notoginseng

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Evaluation of canine lymphocyte proliferation: comparison of three different colorimetric methods with the 3H-thymidine incorporation assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

QS-21: a water-soluble triterpene glycoside adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Evaluation of CD8( ) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Safety Profile of Phase I and II Preventive HIV Type 1 Envelope Vaccination: Experience of the NIAID AIDS Vaccine Evaluation Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Molecular structures of saponins from Quillaja saponaria Molina.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Separation and structural analysis of saponins in a bark extract from Quillaja saponaria Molina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Saponin and sapogenol. XXXIV. Chemical constituents of astragali radix, the root of Astragalus membranaceus Bunge. (1). Cycloastragenol, the 9,19-cyclolanostane-type aglycone of astragalosides, and the artifact aglycone astragenol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Saponin and sapogenol. XXXV. Chemical constituents of astragali radix, the root of Astragalus membranaceus Bunge. (2). Astragalosides I,II and IV, acetylastragaloside I and isoastragalosides I and II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Saponin and sapogenol. XXXVI. Chemical constituents of astragali radix, the root of Astragalus membranaceus Bunge. (3). Astragalosides III,V, and VI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Constituents of Astragalus membranaceus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Saponin and sapogenol. XXXVII. Chemical constituents of astragali radix, the root of Astragalus membranaceus Bunge. (4). Astragalosides VII and VIII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Hemolysis of human erythrocytes with saponin affects the membrane structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

Structural and immunological characterization of the vaccine adjuvant QS-21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.06.016

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.06.016

1 reference

18 March 2018

1 reference

18 March 2018